Myles David C.'s Form 4 filing
Olema Pharmaceuticals, Inc. (OLMA) · filed Dec 23, 2025
- Accession no.
- 0001831216-25-000004
- Filed
- Dec 23, 2025
- Trade date
- Dec 19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.55M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Myles David C.CIK 0001831216 | Officer (CH. DISCOV. & NON-CLIN DEV OFF) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | SSaleDisposed | −1,225 | $28.08 | −$34,398 | 601,656 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −43,729 | $30.40 | −$1,329,361.6 | 557,927 | Direct | |
| Dec 19, 2025 | Common Stock | SSaleDisposed | −6,046 | $31.39 | −$189,783.94 | 551,881 | Direct | |
| Dec 19, 2025 | Common Stock | GGiftDisposed | −9,000 | $0.00 | $0 | 542,881 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.